Cencora, Inc.

Wholesale-Drugs, Proprietaries & Druggists' Sundries·CONSHOHOCKEN, PA·FY end 09/30·CIK 1140859

CEO Pay Ratio

198:1

Robert P. Mauch

CEO Total Comp

$18.3M

Robert P. Mauch

Median Employee

$92,438

Revenue

$321.3B

FY 2025

Net Income

$1.6B

FY 2025

Free Cash Flow

$3.2B

FY 2025

Net Margin

0.5%

Insider Net (180d)

-$7.1M

0 buys / 6 sales

CEO Pay Accountability

CEO comp as % of net income

1.17%

For every $1,000 of profit, $11.75 flows to the CEO.

CEO comp as % of buybacks

4.19%

CEO comp equals 41.9‰ of cash returned to shareholders via buybacks.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$321.3B	$294.0B	$262.2B	$238.6B	$214.0B
Gross Profit	$11.5B	$9.9B	$9.0B	$8.3B	$6.9B
Operating Income	$2.6B	$2.2B	$2.3B	$2.4B	$2.4B
Net Income	$1.6B	$1.5B	$1.7B	$1.7B	$1.5B
Operating CF	$3.9B	$3.5B	$3.9B	$2.7B	$2.7B
Capex	$668.0M	$487.2M	$458.4M	$496.3M	$438.2M
Free Cash Flow	$3.2B	$3.0B	$3.5B	$2.2B	$2.2B
Buybacks	$435.5M	$1.5B	$1.2B	$483.7M	$82.2M
Dividends	$437.1M	$416.2M	$398.8M	$391.7M	$366.6M

Gross Margin	3.6%	3.4%	3.4%	3.5%	3.2%
Operating Margin	0.8%	0.7%	0.9%	1.0%	1.1%
Net Margin	0.5%	0.5%	0.7%	0.7%	0.7%
FCF Margin	1.0%	1.0%	1.3%	0.9%	1.0%
R&D / Revenue	—	—	—	—	—	—
Effective Tax	30.6%	24.2%	19.8%	23.7%	30.5%
Debt / Equity	10.08	12.69	17.11	-48.85	58.51
Buybacks / FCF	13.6%	49.8%	34.2%	21.9%	3.7%

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Robert P. MauchPresident and Chief Executive Officer	$1.4M	$12.0M	—	$4.3M	$622.8K	$18.3M
Steven H. CollisExecutive Chairman*	$1.0M	$6.0M	—	$1.8M	$867.0K	$9.7M
James F. ClearyExecutive Vice President and Chief Financial Officer	$926.1K	$3.8M	—	$1.7M	$116.5K	$6.5M
Elizabeth S. CampbellExecutive Vice President and Chief Legal Officer	$769.2K	$2.9M	—	$1.4M	$112.7K	$5.2M
Silvana BattagliaExecutive Vice President and Chief Human Resources Officer	$664.8K	$1.7M	—	$1.2M	$92.7K	$3.7M